Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner(McGill University), Walter J. Curran(Piedmont Cancer Institute), K. Stelzer(University of Maryland, Baltimore), Peter E. Ricci(University of Maryland, Baltimore), Albert Murtha(University of Maryland, Baltimore), Stephen W. Coons(University of Maryland, Baltimore), Geoffrey Barger(University of Maryland, Baltimore), Minesh P. Mehta(Columbia University), Minhee Won(American College of Radiology), Mark R. Gilbert(Johns Hopkins University SAIS Bologna Center), Paul D. Brown(Mayo Clinic), Dennis E. Bullard(University of Maryland, Baltimore), Erica H. Bell(University of Maryland, Baltimore), John H. Suh(Cleveland Clinic), David Brachman(Barrow Neurological Institute), Arnab Chakravarti(The Ohio State University), Edward G. Shaw(Wake Forest University), Jean-Paul Bahary(University of Maryland, Baltimore), Barbara J. Fisher(University of Maryland, Baltimore), Christopher J. Schultz(Medical College of Wisconsin), Stephanie L. Pugh(American College of Radiology), Harold Kim(Western University)
Cited by 1,042
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k